Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines.

Mahmood M, Casciano DA, Mocan T, Iancu C, Xu Y, Mocan L, Iancu DT, Dervishi E, Li Z, Abdalmuhsen M, Biris AR, Ali N, Howard P, Biris AS.

J Appl Toxicol. 2010 Jan;30(1):74-83. doi: 10.1002/jat.1475.

PMID:
19760634
2.

Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials.

Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y.

Small. 2011 May 23;7(10):1322-37. doi: 10.1002/smll.201100001. Review.

PMID:
21520409
3.

Nanomaterials for in situ cell delivery and tissue regeneration.

Wan AC, Ying JY.

Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):731-40. doi: 10.1016/j.addr.2010.02.002. Review.

PMID:
20156499
4.

Toxicity evaluations of various carbon nanomaterials.

Uo M, Akasaka T, Watari F, Sato Y, Tohji K.

Dent Mater J. 2011;30(3):245-63. Review.

5.

What's new in nanotoxicology? Implications for public health from a brief review of the 2008 literature.

Boczkowski J, Hoet P.

Nanotoxicology. 2010 Mar;4(1):1-14. doi: 10.3109/17435390903428844. Review.

PMID:
20795899
6.

Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications.

Son SJ, Bai X, Lee SB.

Drug Discov Today. 2007 Aug;12(15-16):657-63. Review.

PMID:
17706548
7.

[Hazard identification of nanomaterials].

Tsuda H, Tokunaga H, Hirose A, Kanno J.

Yakugaku Zasshi. 2008 Dec;128(12):1727-32. Review. Japanese.

8.

Testing metal-oxide nanomaterials for human safety.

Landsiedel R, Ma-Hock L, Kroll A, Hahn D, Schnekenburger J, Wiench K, Wohlleben W.

Adv Mater. 2010 Jun 25;22(24):2601-27. doi: 10.1002/adma.200902658. Review.

PMID:
20512811
9.

Environmental implications of nanomaterials: are we studying the right thing?

Turco RF, Bischoff M, Tong ZH, Nies L.

Curr Opin Biotechnol. 2011 Aug;22(4):527-32. doi: 10.1016/j.copbio.2011.05.006. Review.

PMID:
21742482
10.

[Nanosafety studies of nanomaterials about biodistribution and immunotoxicity].

Yoshioka Y.

Yakugaku Zasshi. 2011 Feb;131(2):221-4. Review. Japanese.

11.

Gene delivery by functional inorganic nanocarriers.

Loh XJ, Lee TC.

Recent Pat DNA Gene Seq. 2012 Aug;6(2):108-14. Review.

PMID:
22670611
12.

Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus?

Shvedova AA, Kisin ER, Porter D, Schulte P, Kagan VE, Fadeel B, Castranova V.

Pharmacol Ther. 2009 Feb;121(2):192-204. doi: 10.1016/j.pharmthera.2008.10.009. Review.

PMID:
19103221
13.

Effect of chemical composition and state of the surface on the toxic response to high aspect ratio nanomaterials.

Fubini B, Fenoglio I, Tomatis M, Turci F.

Nanomedicine (Lond). 2011 Jul;6(5):899-920. doi: 10.2217/nnm.11.80. Review.

PMID:
21793679
14.

Hazard assessments of manufactured nanomaterials.

Morimoto Y, Kobayashi N, Shinohara N, Myojo T, Tanaka I, Nakanishi J.

J Occup Health. 2010;52(6):325-34. Review.

15.

Biophysical responses upon the interaction of nanomaterials with cellular interfaces.

Wu YL, Putcha N, Ng KW, Leong DT, Lim CT, Loo SC, Chen X.

Acc Chem Res. 2013 Mar 19;46(3):782-91. doi: 10.1021/ar300046u. Review.

PMID:
23194178
16.

Culture medium-associated physicochemical insights on the cytotoxicity of carbon nanomaterials.

Kong H, Wang L, Zhu Y, Huang Q, Fan C.

Chem Res Toxicol. 2015 Mar 16;28(3):290-5. doi: 10.1021/tx500477y. Review.

PMID:
25580995
17.

Nanomaterials and the human lung: what is known and what must be deciphered to realise their potential advantages?

Jud C, Clift MJ, Petri-Fink A, Rothen-Rutishauser B.

Swiss Med Wkly. 2013 Feb 27;143:w13758. doi: 10.4414/smw.2013.13758. Review.

Items per page

Supplemental Content

Support Center